| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.094 | 0.03 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.03 |